Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Frequency of Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder: The North American Prodromal Synucleinopathy Cohort.

Frequency of Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder: The North American Prodromal Synucleinopathy Cohort. Neurology Elliott, J., Bryant-Ekstrand, M. D., Keil, A. T., Ligman, B. R., Lim, M. M., Zitser, J., During, E. H., Gagnon, J. F., St Louis, E. K., Fields, J. A., Huddleston, D. E., Bliwise, D. L., Avidan, A. Y., Schenck, C. H., McLeland, J., Criswell, S. R., Davis, A. A., Videnovic, A., Lee-Iannotti, J. K., Postuma, R., Boeve, B. F., Ju, Y. E., Miglis, M. G. 2023

Abstract

Although orthostatic hypotension (OH) can be an early feature of autonomic dysfunction in isolated rapid eye movement sleep behavior disorder (iRBD), no large-scale studies have examined the frequency of OH in iRBD. In this study we prospectively evaluated the frequency of OH in a large multicenter iRBD cohort.Participants =18 years of age with video polysomnogram-confirmed iRBD were enrolled through the North American Prodromal Synucleinopathy consortium. All participants underwent 3-minute orthostatic stand testing to assess the frequency of OH, and a ? heart rate/? systolic blood pressure (?HR/?SBP) ratio <0.5 was used to define reduced HR augmentation, suggestive of neurogenic OH. All participants completed a battery of assessments including the Scales for Outcomes in Parkinson's Disease-Autonomic Dysfunction (SCOPA-AUT) and others assessing cognitive, motor, psychiatric and sensory domains.Of 340 iRBD participants (65±10 yrs., 82% male), 93 (27%) met criteria for OH (?HR/?SBP 0.37±0.28; range: 0.0-1.57) and of these, 72 (77%) met criteria for OH with reduced HR augmentation (?HR/?SBP 0.28±0.21; range: 0.0-0.5). Supine hypertension (sHTN) was present in 72% of those with OH. Compared to iRBD participants without OH, those with OH were older, reported older age of RBD symptom onset, and had worse olfaction. There was no difference in autonomic symptom scores as measured by SCOPA-AUT.OH and sHTN are common in iRBD. However, as patients may have reduced autonomic symptom awareness, orthostatic stand testing should be considered in clinical evaluations. Longitudinal studies are needed to clarify the relationship between OH and phenoconversion risk in iRBD.

View details for DOI 10.1212/WNL.0000000000207883

View details for PubMedID 37857496